SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-008642
Filing Date
2024-05-24
Accepted
2024-05-24 16:05:27
Documents
17
Period of Report
2024-05-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sngx-20240523x8k.htm   iXBRL 8-K 35737
2 EX-99.1 sngx-20240523xex99d1.htm EX-99.1 25604
3 GRAPHIC sngx-20240523xex99d1001.jpg GRAPHIC 14345
  Complete submission text file 0001558370-24-008642.txt   246005

Data Files

Seq Description Document Type Size
4 EX-101.SCH sngx-20240523.xsd EX-101.SCH 4345
5 EX-101.DEF sngx-20240523_def.xml EX-101.DEF 3492
6 EX-101.LAB sngx-20240523_lab.xml EX-101.LAB 12255
7 EX-101.PRE sngx-20240523_pre.xml EX-101.PRE 10475
21 EXTRACTED XBRL INSTANCE DOCUMENT sngx-20240523x8k_htm.xml XML 4842
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 24984243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)